-
Allegra captures strong sales
PARIS — Sanofi-Aventis on Thursday reported strong sales out of the gate for its recently switched second-generation antihistamine Allegra.
Allegra generated in excess of $26.7 million within its first month available as a nonprescription allergy treatment in the U.S. market, becoming No. 2 in terms of dollar share of allergy, the company reported.
First-quarter sales of Sanofi’s Consumer Health Care totaled $1.1 billion, representing an increase of 40.3%.
-
Ingles reports positive Q2, half-year results
ASHEVILLE, N.C. — Net sales and net income for Ingles Markets realized a 4% and 38% increase, respectively, during the second quarter ended March 26, the retailer announced Friday.
Ingles reported that second-quarter net sales rose $33.4 million to $870.4 million, while second-quarter net income increased from $5.6 million to $7.7 million.